Analysts Are Bullish on These Healthcare Stocks: LLY, COO

By Ryan Adsit

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eli Lilly & Co (NYSE: LLY) and Cooper Co (NYSE: COO) with bullish sentiments.

Eli Lilly & Co (NYSE: LLY)

In a report released today, Jeffrey Holford from Jefferies reiterated a Buy rating on Eli Lilly & Co (NYSE: LLY), with a price target of $92. The company’s shares closed last Friday at $78.05.

According to TipRanks.com, Holford is a 5-star analyst with an average return of 8.4% and a 72.8% success rate. Holford covers the Healthcare sector, focusing on stocks such as Parnell Pharmaceuticals, Johnson & Johnson, and Sanofi-Aventis Sa.

Eli Lilly & Co has an analyst consensus of Moderate Buy, with a price target consensus of $89.22.

Cooper Co (NYSE: COO)

In a report released today, Anthony Petrone from Jefferies reiterated a Buy rating on Cooper Co (NYSE: COO), with a price target of $220. The company’s shares closed last Friday at $217.46, close to its 52-week high of $218.89.

According to TipRanks.com, Petrone is a 4-star analyst with an average return of 13.8% and a 58.7% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Varian Medical Systems, Haemonetics Corp, and Perrigo Company.

Currently, the analyst consensus on Cooper Co is Strong Buy and the average price target is $215.75, representing a -0.8% downside.

In a report issued on May 23, BMO Capital also reiterated a Buy rating on the stock with a $220 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.